Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice.

MLA

Clark, Rosemary M., et al. “Intranasal Neuropeptide Y1 Receptor Antagonism Improves Motor Deficits in Symptomatic SOD1 ALS Mice.” Annals of Clinical and Translational Neurology, vol. 10, no. 11, Nov. 2023, pp. 1985–99. EBSCOhost, https://doi.org/10.1002/acn3.51885.

APA

Clark, R. M., Clark, C. M., Lewis, K. E. A., Dyer, M. S., Chuckowree, J. A., Hoyle, J. A., Blizzard, C. A., & Dickson, T. C. (2023). Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice. Annals of Clinical and Translational Neurology, 10(11), 1985–1999. https://doi.org/10.1002/acn3.51885

Chicago

Clark, Rosemary M, Courtney M Clark, Katherine E A Lewis, Marcus S Dyer, Jyoti A Chuckowree, Joshua A Hoyle, Catherine A Blizzard, and Tracey C Dickson. 2023. “Intranasal Neuropeptide Y1 Receptor Antagonism Improves Motor Deficits in Symptomatic SOD1 ALS Mice.” Annals of Clinical and Translational Neurology 10 (11): 1985–99. doi:10.1002/acn3.51885.